Home MRK
  Price0.79%   +0.6715
Oct-06-22 06:02AM Why Guardant Health Topped the Market on ThursdayThe Motley Fool
03:49AM Verve's Stock Price Could Continue To Rise Through Clinical Progress - Despite Worries About "DeeperPocketed" CompetitionBenzinga
Oct-06-22 11:02AM GSK's (GSK) PD-1 Inhibitor Drug Meets Lung Cancer Study GoalZacks Investment Research
09:00AM Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending StockZacks Investment Research
Oct-05-22 09:45AM Iovance (IOVA) Focuses on Seeking Nod for Melanoma TherapyZacks Investment Research
Oct-04-22 09:41AM What Happened In The Stock Market Today & 4 Penny Stocks To WatchPennyStocks
Oct-03-22 05:56AM The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It's Very ShortBenzinga
05:45AM Merck (MRK) Gains But Lags Market: What You Should KnowZacks Investment Research
Oct-03-22 09:12AM Will New Drugs Help Bristol Myers (BMY) Combat Generic Pressure?Zacks Investment Research
Oct-02-22 01:33AM Dividend Champion, Contender, And Challenger Highlights: Week Of October 2Seeking Alpha
Oct-01-22 10:30AM What This News Means for MerckThe Motley Fool
Sep-30-22 10:10AM 'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace CompanyBenzinga
08:31AM 10 Analysts Have This to Say About Merck & CoBenzinga
Sep-28-22 01:47AM Merck's (MRK) Keytruda Gets Four New Approvals in JapanZacks Investment Research
10:45AM Bear Market: 2 Safe Stocks to Buy Right NowThe Motley Fool
Sep-28-22 06:20AM Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar?Zacks Investment Research
Sep-27-22 05:45AM Merck (MRK) Dips More Than Broader Markets: What You Should KnowZacks Investment Research
09:53AM Atea (AVIR) Dengue Candidate Gets Fast Track DesignationZacks Investment Research
Sep-26-22 10:30AM Dow Jones ETF Avoids Bear Market: 4 Stocks in GreenZacks Investment Research
01:04AM Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2022 UpdateSeeking Alpha
Sep-24-22 10:00AM A Stock's Price "Tells You Almost Nothing"The Motley Fool
Sep-23-22 11:14AM Merck's (MRK) Stock Up on Januvia Patent Win Against ViatrisZacks Investment Research
10:02AM Pharma Stock Roundup: EU Nod to AZN & RHHBY Drugs, FDA Updates for LLY & MRKZacks Investment Research
Sep-23-22 07:34AM My Take: 4 Strong Growth Stocks to Buy This WeekThe Motley Fool
Sep-22-22 10:50AM Evaxion (EVAX) Enrolls First Patient in Phase IIb Melanoma StudyZacks Investment Research
09:00AM Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?Zacks Investment Research
Sep-21-22 12:16PM Merck (MRK) Resumes HIV Studies on Islatravir With Lower DoseZacks Investment Research
05:52AM 3 Best Dow Jones Stocks of 2022 So Far: Are They Buys Now?The Motley Fool
Sep-19-22 12:21PM Merck's (MRK) Pneumococcal Jab Gets CHMP Endorsement for KidsZacks Investment Research
09:02AM Bristol Myers (BMY) Skin Cancer Drug Gets EC's ApprovalZacks Investment Research
Sep-19-22 06:43AM The Zacks Analyst Blog Highlights AbbVie, Novartis, Merck and AstraZenecaZacks Investment Research
Sep-17-22 07:01AM 26 Incredible Blue-Chip Bargains That Could Change Your LifeSeeking Alpha
Sep-16-22 02:41AM Bristol Myers' (BMY) Opdivo Meets Main Goal in Melanoma StudyZacks Investment Research
09:58AM 4 Large Drug Stocks to Watch as Fundamentals Stay StrongZacks Investment Research
Sep-15-22 10:37AM Why This Monster Stock's Recent Blunders Might Not MatterThe Motley Fool
10:07AM 2 Healthcare Stocks That Could Help Set You Up for LifeThe Motley Fool
Sep-15-22 09:55AM The Zacks Analyst Blog Highlights Merck, Cisco, Morgan Stanley, CME Group and Canadian Natural ResourcesZacks Investment Research
05:26AM The 'Biden Biotech Boom' Will Send This Bargain Dividend SoaringInvesting.com
Sep-14-22 02:41AM Top Analyst Reports for Merck, Cisco & Morgan StanleyZacks Investment Research
02:10AM Corcept (CORT) Up More Than 20% in Past 3 Months: Here's WhyZacks Investment Research
Sep-14-22 01:33AM Key Factors Driving Merck's (MRK) Outperformance This YearZacks Investment Research
10:07AM Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022Benzinga
Sep-14-22 09:40AM Why This 1 Value Stock Could Be a Great Addition to Your PortfolioZacks Investment Research
08:09AM Evercore ISI Group Boosts PT On This Stock By Around 400%, Plus This Analyst Predicts $100 For MerckBenzinga
Sep-14-22 02:23AM Why The CPI Sent The Dow Down By Over 1,200 PointsSeeking Alpha
Sep-13-22 06:56AM Got $1,000? 3 Stocks to Buy and Hold Until RetirementThe Motley Fool
06:20AM Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?Zacks Investment Research
Sep-12-22 11:03AM Analyst Ratings for Merck & CoBenzinga
10:16AM BP To $47? Plus UBS Sees $2,260 For This StockBenzinga
Sep-12-22 06:20AM Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?Zacks Investment Research
Merck & Co., Inc. provides healthcare solutions worldwide. It operates in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The company offers therapeutic and preventive agents to treat cardiovascular diseases, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases. It also provides neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors, and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. The company also provides companion animal products, such as ointments; diabetes mellitus; anthelmintic products; fluralaner products to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. Merck & Co., Inc. has collaborations with Pfizer Inc., AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., IO Biotech, Premier Inc., Cue Biopharma, Inc., Foundation Medicine, Inc., Daiichi Sankyo Company, Limited, and Cold Genesys, Inc. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Cap:    |  Volume (24h):